Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,854.50
+20.00 (1.09%)
Feb 27, 2026, 3:41 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 112.95 billion as of February 27, 2026. Its market cap has increased by 30.03% in one year.
Market Cap
112.95B
Enterprise Value
136.56B
Revenue
23.66B
Ranking
n/a
PE Ratio
18.76
Stock Price
1,854.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 112.95B, an increase of 2,965.89%. That is a compound annual growth rate of 14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 112.95B | -9.54% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Coloplast | 108.40B |
| ALK-Abelló | 47.24B |
| H. Lundbeck | 37.93B |
| Demant | 37.88B |
| Zealand Pharma | 25.93B |
| Ambu A/S | 20.92B |
| Bavarian Nordic | 15.08B |